How long before I lose weight on Wegovy — and what does the evidence show?

The biggest myth: that Wegovy should work immediately

A question our prescribers hear most weeks is some version of: "I've been on Wegovy for two weeks and I've barely lost anything, is it working?" The short answer is: almost certainly yes, just not in the way the question assumes.

The first pen of Wegovy contains the 0.25mg starting dose. That dose exists to let your body adjust, it reduces the nausea and gut discomfort that can come with GLP-1 medicines, and it is titrated upward every four weeks by your prescriber: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, before reaching the 2.4mg maintenance dose. Each step builds on the last. Expecting significant weight loss at 0.25mg is a bit like judging a kettle by how warm the water is thirty seconds in.

This is not a flaw in the medicine. It is the licensed design. The appetite-suppressing effect strengthens as the dose rises. For most people, the clearest shift in hunger and food intake becomes apparent somewhere between the 1.0mg and 2.4mg phases, which typically means months two through five of treatment. Some people notice the change earlier; others later. Biology is not uniform.

The NICE appraisal of semaglutide (Wegovy) sets a practical checkpoint: if less than 5% weight loss has occurred after six months on the maintenance dose, continuing treatment should be reviewed with a prescriber. That milestone gives a useful sense of how long genuine assessment of the medicine's effect actually takes. You can read NICE's recommendation on semaglutide (TA875) for the full clinical context.

What the clinical trial evidence actually shows, and when

The STEP 1 trial followed 1,961 adults with obesity or overweight plus at least one weight-related condition over 68 weeks, comparing 2.4mg weekly semaglutide against placebo alongside lifestyle support. Average weight loss in the active group was around 15% of body weight. That figure is the number most often quoted; what is quoted less often is the shape of that loss over time.

Weight reduction in the trial was not front-loaded. Participants were still accumulating meaningful loss at week 44, week 52, week 60. The curve flattens toward the end of the trial but rarely becomes flat within the first three months. This matters because people who stop treatment early (frustrated by slow early progress) often do so before they have reached the dose or the duration at which the medicine works best.

The STEP 1 paper, published in the New England Journal of Medicine, remains the primary evidence base for understanding this timeline. The newer Wegovy 7.2mg maintenance dose, approved by the MHRA in 2026, reported around 20.7% average loss over 72 weeks in trials, a higher ceiling, but again one reached gradually over a long treatment course.

If you are exploring how long Wegovy takes to work in more detail, the mechanism behind the dose-response relationship is worth understanding alongside these figures.

Factors that shape how quickly weight loss begins

Two people on the same dose of Wegovy can lose weight at quite different rates. Several things influence this, and none of them mean the treatment is failing.

Starting BMI plays a role: someone with a higher starting weight may see larger early absolute losses even if the percentage is similar to someone lighter. Adherence to diet and activity matters substantially, Wegovy is licensed alongside a reduced-calorie diet and increased physical activity, not instead of them. The NHS patient information on semaglutide covers how lifestyle adjustments work alongside the medicine.

Gastrointestinal side effects during dose escalation can also influence early results. Nausea, which is common in the early weeks, may itself reduce appetite and food intake temporarily, this is not the same as the sustained appetite modulation the higher doses produce. Constipation can occasionally cause the scale to move less than expected early on. Both tend to settle.

Some people metabolise semaglutide differently, and individual variation in gut hormone response is real. There is no reliable early predictor of who will be a fast or slower responder. The consistent finding across the trial data is that the people who stay on treatment long enough reach the most significant results.

For people thinking about how long to take Wegovy, the evidence on what happens after stopping is just as relevant as what happens during treatment.

Setting realistic expectations for the first six months

A realistic picture of how long before weight loss on Wegovy, based on the evidence: modest changes in the first month or two, more noticeable progress from months three to five, and the clearest assessment possible only after reaching and staying at the maintenance dose for at least eight to twelve weeks.

Tracking progress by clothes fit, energy levels, and waist measurement alongside the scale gives a fuller picture than any single weigh-in. If you want to understand how long before you see weight loss on Wegovy in a way that accounts for those visible and physical signs as well as the number on the scale, the detail behind that question is worth reading. Weekly fluctuations are normal and often unrelated to fat loss.

If you are considering the full picture of what Wegovy involves (including the dose schedule, eligibility, and access options) our treatment overview covers the detail. For those exploring weight-loss treatment options more broadly, there is a useful comparison of what is currently licensed in the UK.

Understanding the timeline helps with something practical too: how to access Wegovy through a legitimate, clinically supervised route matters as much as knowing what to expect once treatment starts. Prescription medicines dispensed without proper oversight carry real risks, fake pens and unlicensed sellers are an ongoing concern flagged by the MHRA.

Speak to our prescribers if you have questions about whether Wegovy is the right option for you, or what a realistic weight-loss timeline might look like given your individual circumstances. A free consultation is the first step.